Market News & Trends
OncoMed Presents Initial First-in-Human Data
OncoMed Pharmaceuticals Inc. presented initial first-in-human data from its ongoing Phase I clinical trials of anti-DLL4/VEGF bispecific (OMP-305B83) and anti-RSPO3 (OMP-131R10) antibodies in two posters…
Novan Announces Statistically Significant Phase II Clinical Trial Results
Novan, Inc. recently announced top-line results from the company’s Phase II clinical trial with SB206 for the treatment of genital warts caused by human papillomavirus,…
Cellular Biomedicine Group Approved to Commence Phase I Trial
Cellular Biomedicine Group Approved to Commence Phase I Trial Cellular Biomedicine Group Inc. (CBMG) recently announced the approval and commencement of patient enrollment in China…
Catalent Acquires Company to Expand Softgel Development & Manufacturing
Catalent, Inc. recently announced it has agreed to acquire Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency, and conventional pharmaceutical…
Ablynx Achieves First Milestone From Novo Nordisk
Ablynx recently announced it has achieved an initial discovery milestone with a multi-specific Nanobody construct as part of its collaboration with Novo Nordisk, triggering a…
Stealth Biotherapeutics Announces Positive Phase II Clinical Trial Findings
Stealth BioTherapeutics recently presented results from the EVOLVE trial, which demonstrated that a single dose of elamipretide prior to renal artery angioplasty and stenting procedures…
TKL Research Agrees to Sell Clinical Trials Division
TKL Research, a dermatology specialty clinical research organization (CRO), recently announced it has signed an agreement to sell its Clinical Trials Division (CTD) to QuintilesIMS. Upon…
IP Assets of Biopharmaceuticals Delivery Specialists Brought to Market by Metis Partners
The IP assets of a recognized leader in the bioformulation and drug delivery industry, XstalBio Limited, which is behind CentuRecon – a patent-backed reconstitution technology…
West Announces Expanded Contract Manufacturing Capabilities in Ireland
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot…
Honeywell Launces New Research Chemicals Business to Optimize Product Partnerships With Researchers
Honeywell recently announced the launch of a new business, Honeywell Research Chemicals, that will now include several brands and solvent and inorganic chemical products that…
Mustang Bio Presents Clinical & Preclinical Data on MB-101 for Treatment of Glioblastoma
Mustang Bio, Inc., a Fortress Biotech company, recently announced that Phase I clinical data and preclinical data on its MB-101 [IL13Rα2-specific Chimeric Antigen Receptor–engineered CAR…
Biogen Renews License With Absorption Systems
Absorption Systems, a world leader in novel test systems for drug transporters, recently announced the renewal of a technology licensing deal with Biogen. After years…
Vetter: Choosing the Right Diluent to Help Maximize Success
Choose the Right Diluent to Help Maximize Success The biologics market continues to rise, expecting to reach $250 billion by 2024. Due to the unstable nature…
Healthcare Companies Must Embrace New Funding Sources as Venture Investment Continues to Decline
Although the life sciences industry remains an attractive investment area, the healthcare sector has seen a decline in venture investments, particularly for early stage investments,…
Tiziana Life Sciences Announces New Data With Foralumab, a Fully Human Anti-CD3 Antibody
Tiziana Life Sciences plc, the clinical-stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, recently announced new data from animal studies demonstrating the…
The Human Vaccines Project & Boehringer Ingelheim Partner to Accelerate the Development of Cancer Vaccines & Immunotherapies
The Human Vaccines Project and Boehringer Ingelheim are pleased to announce a 3-year collaboration agreement to support their mutual objective to decode the human immune…
Ropack Announces International Serialization Hub
Ropack Pharma Solutions recently announced it will launch an international serialization hub as a practical solution for pharmaceutical organizations and contract packaging partners that are…
Pharmaceutical Companies Lose $637 Billion in Revenue Annually
HealthPrize Technologies recently announced the publication of an update to a research paper co-authored with Capgemini estimating annual pharmaceutical revenue losses of $637 billion due…
PCI Clinical Services Announces Significant Expansion
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is extending its current Cryogenic storage capabilities to its Rockford, IL, operations, complementing the specialized capability…
Agilis Biotherapeutics Announces First Patient Treated in Phase IIb Clinical Study
Agilis Biotherapeutics recently announced that the first patient in the Phase IIb clinical study for its gene therapy treatment of Aromatic L-Amino Acid Decarboxylase (AADC)…
